Neurology and Neurosurgery - Global Neurology Academy

209-224 of 433

Advancing Schizophrenia Care: Challenges and Promising New Therapies
Advancing Schizophrenia Care: Challenges and Promising New Therapies
NeuroFrontiers
Advancing Schizophrenia Care: Challenges and Promising New Therapies
- Charles Turck, PharmD, BCPS, BCCCP
- Andrew J. Cutler, MD
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiers
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
- Clifford Jack Jr., MD
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
- Clifford Jack Jr., MD
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
- Ashley Baker, MSN, PMHNP
- Suzanne E. Schindler, MD, PhD
Diagnosing Myasthenia Gravis: The Impact of Social Media
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's Roundtable
Diagnosing Myasthenia Gravis: The Impact of Social Media
- Ashley Baker, MSN, PMHNP
- Vishnu Pandurangadu, MD/MBA, FACEP
- Pritikanta Paul, MD
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
NeuroFrontiers
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiers
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
NeuroFrontiers
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
- John A. Morren, MD, FAAN, FAANEM
Bridging the Gap to Improved Schizophrenia Treatment Options
Bridging the Gap to Improved Schizophrenia Treatment Options
NeuroFrontiers
Bridging the Gap to Improved Schizophrenia Treatment Options
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
NeuroFrontiers
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
NeuroFrontiers
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
- Brian P. McDonough, MD, FAAFP
- John R. Corboy, MD
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
NeuroFrontiers
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
- John Brandsema, MD
Continuum of Care: Managing DMD in Pediatric and Adult Patients
Continuum of Care: Managing DMD in Pediatric and Adult Patients
NeuroFrontiers
Continuum of Care: Managing DMD in Pediatric and Adult Patients
- John Brandsema, MD
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
NeuroFrontiers
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
- Charles Turck, PharmD, BCPS, BCCCP
- John Brandsema, MD
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
NeuroFrontiers
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
- Charles Turck, PharmD, BCPS, BCCCP
- Jasmohan Bajaj, MD
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
NeuroFrontiers
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
- Charles Turck, PharmD, BCPS, BCCCP
- Dr. Robert J. Shmookler Reis, PhD
- Dr. Srinivas Ayyadevara, PhD

14/11